UCTS PPVIN completes Phase One of vaccination ahead of schedule

KUCHING: An industrial vaccination centre (PPVIN) at the University College of Technology Sarawak (UCTS) concluded Phase One of its vaccination programme three days ahead of schedule.

Pansar Berhad (Pansar), in a statement on Tuesday (July 6), said the PPVIN was formed by bringing together over 100 local companies to pool resources under one roof to create a unified vaccination centre.

“The PPVIN concept intensifies and speeds up the vaccination programme while allowing companies to ensure all their employees, tenants and business partners are vaccinated together.

“The PPVIN at UCTS was able to be established thanks to the close coordination between the Covid-19 Immunisation Task Force (CITF), Protect Health Corporation Sdn Bhd, Pansar, Segi Medical Clinic as the Partner Healthcare Organiser (HCO), and UCTS.”

Pansar also expressed its gratitude to the government for approving the PPVIN concept, as well as the Sibu business community for banding together to protect their employees and help accelerate the vaccination process.

“We would also like to thank Segi Medical Clinic for providing medical personnel, UCTS for permitting us to use their facility, and the frontline staff and volunteers at UCTS PPVIN who have worked tirelessly.”

To date, 17,335 recipients have signed up to be vaccinated at UCTS PPVIN, of which 13,648 signed up for Phase 1, and an additional 3,687 for Phase 2.

“UCTS PPVIN started with a target of vaccinating only 1,000 people per day but thanks to everyone’s assistance, the capacity was increased to 2,000 people per day.

“However, since July 2, the PPVIN has been operating at a rate of around 2,400 vaccinations per day.

“The approval for this PPVIN to be expanded to a Mobile PPVIN is in process. Sign-ups are only done through companies, and no walk-ins or individual sign-ups are accepted.”

Pansar is celebrating its 60th anniversary this year, and the PPVIN at UCTS is one of the ways the company is giving back to the community.